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Clinical doses of therapeutic proteins range up to 2 mg/kg bodyweigth per patient and even higher. For patient 
convenience and competitiveness, subcutaneous (s.c.) applications are required. Therefore, liquid formulations 
for s.c. applications can reach concentrations of up to 200 mg/ml. One key parameter for the development of 
biotherapeutics as high concentrated liquid formulations (HCLF) is viscosity. Consequently, high solution 
viscosity is challenging due to e.g. impeded syringeablitiy and injectability that directly link to patient 
inconvenience, and high shear stress that potentially impair protein inherent stability. Following Jezek et al. 
2011, we consider protein concentrations of >100 mg/ml as “highly concentrated”.   
 
During early phases in development of biopharmaceutics only limited material is available. Therefore, prediction 
of the solution viscosity at higher concentrations (e.g. for HCLF conditions), if required, will be of great benefit. In 
this study, we applied different approaches comprehensively investigating parameters describing protein-protein 
interaction, protein hydration, protein conformation at different concentrations, and the volume fraction of the 
protein molecule in solution. At a molecular level, Protein-Protein Interaction (PPI) are a result of electrostatic-
interaction, van-der-Waal (vdW)-forces and hydrophobic forces of bi- or multimodal interaction as well as 
protein-excipients interaction. At the macroscopic level, these parameters describe a crucial influence on the 
protein-stability and its rheological behavior in solution. However, during formulation development commonly 
evaluated PPI parameter such as the second virial coefficient (B22), and/or the concentration- dependent 
diffusion coefficient (kD). These parameters only describe interactions in dilute conditions, which poses 
limitations in predicting interactions at high protein concentrations. At dilute conditions, mostly electrostatic 
double layer repulsion and charge-shielding effects of buffer and excipients components dominate. In contrast, 
at high concentration, distances between individual molecules are narrowed, and thus attractive forces such as 
vdW interactions are predominantly present. Therefore, a direct correlation of PPI parameter obtained from 
dilute to crowded conditions is only a shaky compromise.  The mechanisms and principles driving the formation 
of highly viscose systems are not fully understood, especially at the molecular level. As a consequence, the 
attempts to reduce viscosity are often left to chance. In a case study, we evaluated the behaviour of 
concentrated protein formulations under high-frequency shear excitation in the MHz range. As a result, we 
propose an explanation for interaction potentials between individual protein molecules linked to high solution 
viscosity by extending the complex colloid theory. Multiple attraction forces result in a complex viscous behavior, 
the formation of a transient micro-rheological network of multiple interacting protein molecules, and the 
formation of an elastic modulus. In order to lower the viscosity, such multiple interactions have to be disrupted 
and disordered by different excipients.   
 
However, the interaction potential is correlated to the characteristics of each mAb molecule and can be altered 
by excipients in a defined way. By relating low concentration PPI measurements and wet-lab determined 
molecular characteristics (e.g. effective surface charge, dipole moment) it is possible to predicts the potency for 
describing a high viscosity for each mAb. Knowing the effects of pH and different buffer and excipients, a guided 
development for decreasing the viscosity by different excipients and formulation conditions is possible. High 
frequency rheology allows a rapid and early evaluation of the viscosity properties of early candidates and thus 
support subsequent formulation development. 
 
 
